Handling Lot Sizing/Job Scheduling Synchronization through Path Search Algorithms [PDF]
Alain Quilliot, Aurélien Mombelli
doaj +1 more source
Additive Manufacturing of Bio-Based PA11 Composites with Recycled Short Carbon Fibers: Stiffness-Strength Characterization. [PDF]
Brauner C +6 more
europepmc +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
In vitro toxicity assessment of uranium particulates on different human lung epithelial cell models. [PDF]
Moore SC +10 more
europepmc +1 more source
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai +28 more
wiley +1 more source
Extending the Linear Dynamic Range of Single Particle ICP-MS for the Quantification of Microplastics. [PDF]
Caceres GC +4 more
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Digital phenotyping using smartphones could help steer mental health treatment. [PDF]
Adam D.
europepmc +1 more source
Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte +13 more
wiley +1 more source
Recycling, Remanufacturing and Applications of Semi-Long and Long Carbon Fibre from Waste Composites: A Review. [PDF]
Abdi B, Wang Y, Gong H, Su M.
europepmc +1 more source

